These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 23613828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
    Langerud J, Jarhelle E, Van Ghelue M, Ariansen SL, Iversen N.
    Hum Genomics; 2018 Nov 20; 12(1):51. PubMed ID: 30458859
    [Abstract] [Full Text] [Related]

  • 3. Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.
    Bassi N, Hovland HN, Rasheed K, Jarhelle E, Pedersen N, Mchaina EK, Bakkan SME, Iversen N, Høberg-Vetti H, Haukanes BI, Knappskog PM, Aukrust I, Ognedal E, Van Ghelue M.
    BMC Cancer; 2023 Apr 21; 23(1):368. PubMed ID: 37085799
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.
    Lee MS, Green R, Marsillac SM, Coquelle N, Williams RS, Yeung T, Foo D, Hau DD, Hui B, Monteiro AN, Glover JN.
    Cancer Res; 2010 Jun 15; 70(12):4880-90. PubMed ID: 20516115
    [Abstract] [Full Text] [Related]

  • 5. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.
    Carvalho M, Pino MA, Karchin R, Beddor J, Godinho-Netto M, Mesquita RD, Rodarte RS, Vaz DC, Monteiro VA, Manoukian S, Colombo M, Ripamonti CB, Rosenquist R, Suthers G, Borg A, Radice P, Grist SA, Monteiro AN, Billack B.
    Mutat Res; 2009 Jan 15; 660(1-2):1-11. PubMed ID: 18992264
    [Abstract] [Full Text] [Related]

  • 6. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
    Fernandes VC, Golubeva VA, Di Pietro G, Shields C, Amankwah K, Nepomuceno TC, de Gregoriis G, Abreu RBV, Harro C, Gomes TT, Silva RF, Suarez-Kurtz G, Couch FJ, Iversen ES, Monteiro ANA, Carvalho MA.
    J Biol Chem; 2019 Apr 12; 294(15):5980-5992. PubMed ID: 30765603
    [Abstract] [Full Text] [Related]

  • 7. Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.
    Tram E, Savas S, Ozcelik H.
    PLoS One; 2013 Apr 12; 8(5):e62468. PubMed ID: 23704879
    [Abstract] [Full Text] [Related]

  • 8. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk.
    Petitalot A, Dardillac E, Jacquet E, Nhiri N, Guirouilh-Barbat J, Julien P, Bouazzaoui I, Bonte D, Feunteun J, Schnell JA, Lafitte P, Aude JC, Noguès C, Rouleau E, Lidereau R, Lopez BS, Zinn-Justin S, Caputo SM, UNICANCER Genetic Group BRCA network.
    Mol Cancer Res; 2019 Jan 12; 17(1):54-69. PubMed ID: 30257991
    [Abstract] [Full Text] [Related]

  • 9. BRCA1/2 missense mutations and the value of in-silico analyses.
    Sadowski CE, Kohlstedt D, Meisel C, Keller K, Becker K, Mackenroth L, Rump A, Schröck E, Wimberger P, Kast K.
    Eur J Med Genet; 2017 Nov 12; 60(11):572-577. PubMed ID: 28807866
    [Abstract] [Full Text] [Related]

  • 10. Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1.
    Carvalho RS, Abreu RB, Velkova A, Marsillac S, Rodarte RS, Suarez-Kurtz G, Iversen ES, Monteiro AN, Carvalho MA.
    PLoS One; 2014 Nov 12; 9(5):e97766. PubMed ID: 24845084
    [Abstract] [Full Text] [Related]

  • 11. Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.
    Jarhelle E, Riise Stensland HM, Mæhle L, Van Ghelue M.
    Fam Cancer; 2017 Jan 12; 16(1):1-16. PubMed ID: 27495310
    [Abstract] [Full Text] [Related]

  • 12. Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions.
    Hovland HN, Mchaina EK, Høberg-Vetti H, Ariansen SL, Sjursen W, Van Ghelue M, Haukanes BI, Knappskog PM, Aukrust I, Ognedal E.
    Genes (Basel); 2023 Jan 19; 14(2):. PubMed ID: 36833189
    [Abstract] [Full Text] [Related]

  • 13. Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.
    Quiles F, Menéndez M, Tornero E, del Valle J, Teulé À, Palanca S, Izquierdo A, Gómez C, Campos O, Santamaria R, Brunet J, Capellá G, Feliubadaló L, Lázaro C.
    Breast Cancer Res Treat; 2016 Jan 19; 155(2):253-60. PubMed ID: 26780556
    [Abstract] [Full Text] [Related]

  • 14. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F, Salhi N, Bakour R, Adane S, Boualga K, Maillet P.
    Dis Markers; 2012 Jan 19; 32(6):343-53. PubMed ID: 22684231
    [Abstract] [Full Text] [Related]

  • 15. Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling.
    Moghadasi S, Hofland N, Wouts JN, Hogervorst FB, Wijnen JT, Vreeswijk MP, van Asperen CJ.
    J Med Genet; 2013 Feb 19; 50(2):74-9. PubMed ID: 23231788
    [Abstract] [Full Text] [Related]

  • 16. Inter-BRCT linker is probably the most intolerant region of the BRCA1 BRCT domain.
    Yadegari F, Farahmand L, Esmaeili R, Zarinfam S, Majidzadeh-A K.
    J Biomol Struct Dyn; 2024 Jul 19; 42(11):5734-5746. PubMed ID: 37948190
    [Abstract] [Full Text] [Related]

  • 17. Toward classification of BRCA1 missense variants using a biophysical approach.
    Rowling PJ, Cook R, Itzhaki LS.
    J Biol Chem; 2010 Jun 25; 285(26):20080-7. PubMed ID: 20378548
    [Abstract] [Full Text] [Related]

  • 18. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
    Lovelock PK, Healey S, Au W, Sum EY, Tesoriero A, Wong EM, Hinson S, Brinkworth R, Bekessy A, Diez O, Izatt L, Solomon E, Jenkins M, Renard H, Hopper J, Waring P, Tavtigian SV, Goldgar D, Lindeman GJ, Visvader JE, Couch FJ, Henderson BR, Southey M, Chenevix-Trench G, Spurdle AB, Brown MA, kConFab Investigators.
    J Med Genet; 2006 Jan 25; 43(1):74-83. PubMed ID: 15923272
    [Abstract] [Full Text] [Related]

  • 19. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
    Ernst C, Hahnen E, Engel C, Nothnagel M, Weber J, Schmutzler RK, Hauke J.
    BMC Med Genomics; 2018 Mar 27; 11(1):35. PubMed ID: 29580235
    [Abstract] [Full Text] [Related]

  • 20. Classification of BRCA1 missense variants of unknown clinical significance.
    Phelan CM, Dapic V, Tice B, Favis R, Kwan E, Barany F, Manoukian S, Radice P, van der Luijt RB, van Nesselrooij BP, Chenevix-Trench G, kConFab, Caldes T, de la Hoya M, Lindquist S, Tavtigian SV, Goldgar D, Borg A, Narod SA, Monteiro AN.
    J Med Genet; 2005 Feb 27; 42(2):138-46. PubMed ID: 15689452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.